Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031210023Completed
Randomised, double-blind trial comparing Suvorexant 20 mg sequence with Placebo sequence (2 arms). Primary endpoint: Primary: Effect of suvorexant on 8-hour sleep energy metabolism. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031210023.